Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-11 Sale |
2024-11-12 4:15 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
10,700 | $36.24 | $387,768 | 130,275 (Direct) |
View |
| 2023-11-16 Sale |
2023-11-20 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
2,500 | $28.01 | $70,025 | 117,089 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-22 Option Award |
2025-02-24 5:47 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
5,369 | $0 | 135,644 (Direct) |
View |
| 2025-02-19 Option Award |
2025-02-21 4:50 pm |
N/A 2035-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
11,771 | $0 | 142,046 (Direct) |
View |
| 2024-11-11 Exercise |
2024-11-12 4:15 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
20,000 | $9.13 | 130,275 (Direct) |
View |
| 2024-11-11 Exercise |
2024-11-12 4:15 pm |
2016-03-03 2025-03-03 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
20,000 | $0 | 130,275 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:04 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
3,886 | $0 | 120,975 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:02 pm |
N/A 2034-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
13,621 | $0 | 130,710 (Direct) |
View |
| 2023-11-16 Exercise |
2023-11-20 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
7,457 | $9.24 | 117,089 (Direct) |
View |
| 2023-11-16 Exercise |
2023-11-20 5:00 pm |
2015-01-21 2024-01-21 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
7,457 | $0 | 117,089 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:02 pm |
N/A 2033-02-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
10,179 | $0 | 122,311 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 5:08 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
3,882 | $0 | 112,132 (Direct) |
View |
| 2018-04-17 Ownership |
2023-02-08 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
2,203 | $0 | 108,250 (Direct) |
View |
| 2022-12-28 Exercise |
2022-12-30 5:01 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
8,722 | $7.9 | 110,453 (Direct) |
View |
| 2022-12-28 Exercise |
2022-12-30 5:01 pm |
2014-02-05 2023-02-05 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
8,722 | $0 | 110,453 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:23 pm |
2023-02-22 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
10,729 | $0 | 112,460 (Direct) |
View |
| 2022-02-19 Option Award |
2022-02-23 4:20 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
4,222 | $0 | 101,731 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 6:46 pm |
2022-02-19 2031-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
11,587 | $0 | 109,096 (Direct) |
View |